These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17010801)

  • 1. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy.
    DeWitt MM; MacLeod HM; Soliven B; McNally EM
    J Am Coll Cardiol; 2006 Oct; 48(7):1396-8. PubMed ID: 17010801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between phospholamban gene mutation and dilated cardiomyopathy in the Chengdu area].
    Chen XY; Rao L; Zhou B; Zhang L; Chen H; Wang YP; Wang B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):683-5. PubMed ID: 16235537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.
    Posch MG; Perrot A; Geier C; Boldt LH; Schmidt G; Lehmkuhl HB; Hetzer R; Dietz R; Gutberlet M; Haverkamp W; Ozcelik C
    Heart Rhythm; 2009 Apr; 6(4):480-6. PubMed ID: 19324307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation.
    Medin M; Hermida-Prieto M; Monserrat L; Laredo R; Rodriguez-Rey JC; Fernandez X; Castro-Beiras A
    Eur J Heart Fail; 2007 Jan; 9(1):37-43. PubMed ID: 16829191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in a Northern Greek population.
    Kalemi T; Efthimiadis G; Zioutas D; Lambropoulos A; Mitakidou A; Giannakoulas G; Vassilikos V; Karvounis H; Kotsis A; Parharidis G; Louridas G
    Biochem Genet; 2005 Dec; 43(11-12):637-42. PubMed ID: 16382369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience.
    van Spaendonck-Zwarts KY; van Rijsingen IA; van den Berg MP; Lekanne Deprez RH; Post JG; van Mil AM; Asselbergs FW; Christiaans I; van Langen IM; Wilde AA; de Boer RA; Jongbloed JD; Pinto YM; van Tintelen JP
    Eur J Heart Fail; 2013 Jun; 15(6):628-36. PubMed ID: 23349452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies.
    Fish M; Shaboodien G; Kraus S; Sliwa K; Seidman CE; Burke MA; Crotti L; Schwartz PJ; Mayosi BM
    Sci Rep; 2016 Feb; 6():22235. PubMed ID: 26917049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation.
    Hershberger RE; Hanson EL; Jakobs PM; Keegan H; Coates K; Bousman S; Litt M
    Am Heart J; 2002 Dec; 144(6):1081-6. PubMed ID: 12486434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PLN nonsense variant causes severe dilated cardiomyopathy in a novel autosomal recessive inheritance mode.
    Li Z; Chen P; Xu J; Yu B; Li X; Wang DW; Wang DW
    Int J Cardiol; 2019 Mar; 279():122-125. PubMed ID: 30638982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
    Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
    Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.
    Haghighi K; Kolokathis F; Gramolini AO; Waggoner JR; Pater L; Lynch RA; Fan GC; Tsiapras D; Parekh RR; Dorn GW; MacLennan DH; Kremastinos DT; Kranias EG
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1388-93. PubMed ID: 16432188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy.
    Te Rijdt WP; van der Klooster ZJ; Hoorntje ET; Jongbloed JDH; van der Zwaag PA; Asselbergs FW; Dooijes D; de Boer RA; van Tintelen JP; van den Berg MP; Vink A; Suurmeijer AJH
    Cardiovasc Pathol; 2017; 30():23-26. PubMed ID: 28759816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations.
    Truszkowska GT; Bilińska ZT; Kosińska J; Śleszycka J; Rydzanicz M; Sobieszczańska-Małek M; Franaszczyk M; Bilińska M; Stawiński P; Michalak E; Małek ŁA; Chmielewski P; Foss-Nieradko B; Machnicki MM; Stokłosa T; Ponińska J; Szumowski Ł; Grzybowski J; Piwoński J; Drygas W; Zieliński T; Płoski R
    BMC Med Genet; 2015 Apr; 16():21. PubMed ID: 25928149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial dilated cardiomyopathy with troponin T K210del mutation.
    Martins E; Silva-Cardoso J; Alves C; Pereira H; Soares B; Damasceno A; Abreu-Lima C; Amorim A; Rocha-Gonçalves F
    Rev Port Cardiol; 2006 Mar; 25(3):295-300. PubMed ID: 16789403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 15 candidate genes for dilated cardiomyopathy in the Newfoundland dog.
    Wiersma AC; Stabej P; Leegwater PA; Van Oost BA; Ollier WE; Dukes-McEwan J
    J Hered; 2008; 99(1):73-80. PubMed ID: 17998275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy.
    Chiu C; Tebo M; Ingles J; Yeates L; Arthur JW; Lind JM; Semsarian C
    J Mol Cell Cardiol; 2007 Sep; 43(3):337-43. PubMed ID: 17655857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation.
    Müller T; Krasnianski M; Witthaut R; Deschauer M; Zierz S
    Neuromuscul Disord; 2005 May; 15(5):372-6. PubMed ID: 15833432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome and risk stratification in dilated cardiolaminopathies.
    Pasotti M; Klersy C; Pilotto A; Marziliano N; Rapezzi C; Serio A; Mannarino S; Gambarin F; Favalli V; Grasso M; Agozzino M; Campana C; Gavazzi A; Febo O; Marini M; Landolina M; Mortara A; Piccolo G; Viganò M; Tavazzi L; Arbustini E
    J Am Coll Cardiol; 2008 Oct; 52(15):1250-60. PubMed ID: 18926329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.